The treatment with dopamine agonists are not associated with increased prevalence of cardiac-valve regurgitation in patients with prolactinomas and acromegalia

Marta Puma, C Perela Alvarez, Fernándo Domínguez(Hospital Universitario Puerta de Hierro Majadahonda), Beatriz Lecumberri(Hospital Universitario La Paz), Luis Pallardó, Ana Gomez Bastero Fernandez, Manuel Vicente Salinas Martín, Mar Moreno Yangüela

13th European Congress of Endocrinology

April 1, 2011

Cited by 0

Related Papers

Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

|Journal of the American College of Cardiology|2016|472

Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths

|European Heart Journal|2017|373

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement

|Nature Reviews Endocrinology|2018|346

Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

|Circulation|2019|346

Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis

|JACC. Cardiovascular imaging|2019|258